Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2015Clinical Cancer ResearchOpen Access

Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3 /ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group

View Full Paper
Ask AI
Bookmark
Share

Authors

KTKatherine TarlockTATodd A. AlonzoRGRobert B. Gerbing

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tarlock et al. (2015) studied this question.

synapsesocial.com/papers/6a7a8f7714b028facf0e6ddahttps://doi.org/10.1158/1078-0432.ccr-15-1349
View Full Paper
Ask AI
Bookmark
Share